| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.59 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |